Search

Snakebite envenoming remains a significant global health challenge, with high mortality and morbidity rates persisting despite decades of medical attention. Each year, millions are affected by venomous snakebites, often resulting in death or severe disability. Snake venoms exhibit diverse bioactivities, including hemorrhagic, inflammatory, cytotoxic, cardiotoxic, and neurotoxic effects, mainly due to complex mixtures of toxin-rich proteins. Although considerable research has been undertaken, the majority of venom components remain uncharacterized. Recent advancements in proteomics and bioinformatics have enabled more detailed exploration of venom profiles, facilitating the identification and functional prediction of novel toxins. Computational approaches now enable modeling of toxin-target interactions, aiding understanding of venom mechanisms. This review also explores the emerging role of medicinal plants in snakebite treatment, alongside conventional antivenoms. Emphasis is placed on the urgent need to improve access to safe, affordable, and effective antivenoms in low-income tropical regions and to promote their appropriate clinical use.

The growing use of muscle-enhancing steroids, particularly anabolic-androgenic steroids (AAS), has raised significant concerns about their potential adverse effects on cardiovascular health, with heart attacks being a key risk. This study offers an in-depth exploration of the relationship between muscle-enhancing drugs and heart attacks. It examines the physiological processes by which steroids may lead to cardiovascular complications, such as hypertension, dyslipidemia, atherosclerosis, and thrombosis. The research also evaluates the epidemiological data that links steroid use to a higher likelihood of heart attacks and other cardiovascular incidents. In addition, the study addresses the ethical issues surrounding steroid use in sports and fitness, as well as the regulatory measures in place to combat abuse. The importance of interdisciplinary collaboration and evidence-driven strategies to tackle this public health challenge is emphasized. Ultimately, the study advocates increased awareness, more extensive research, and stronger preventive efforts to reduce the cardiovascular risks associated with muscle-enhancing steroids, while encouraging safer alternatives for fitness enhancement.